Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04151550Not ApplicableCompleted

Safety & Efficacy of the Laser Scleral Microporation Procedure (Philippines)

Role: lead

NCT05068479Not ApplicableTerminated

Safety & Efficacy of the Laser Scleral Microporation Procedure

Role: lead

NCT04151446Not ApplicableTerminated

Safety & Efficacy of the Laser Scleral Microporation Procedure (Taiwan)

Role: lead

NCT01491360Not ApplicableCompleted

LaserACE® Procedure Restore Visual Function and Range of Accommodation LaserACE® Procedure

Role: lead

All 4 trials loaded